Step 1 of 8
Presentation & Red-Flag Screening
Paediatric (failed screen, speech/language delay) and adult (hearing loss, fullness) presentations; adult unilateral OME is NPC until proven otherwise
OME presents very differently across age. In children it is frequently silent and detected indirectly — a failed hearing screen, speech or language delay, poor school performance, behavioural concerns, inattention, balance disturbance, mouth breathing, or an incidental finding. In adults it presents with hearing loss, ear fullness, aural pressure, autophony, tinnitus, or a unilateral middle-ear effusion.
The cardinal red flag governs the adult presentation: adult unilateral OME — especially of new onset, persistent, and with no previous history of OME — is nasopharyngeal carcinoma until proven otherwise, because a nasopharyngeal tumour obstructing the Eustachian-tube orifice produces a unilateral effusion. Associated neck mass, nasal obstruction, epistaxis, cranial neuropathy or weight loss heightens the concern. The patient undergoes nasopharyngoscopy with imaging to evaluate for nasopharyngeal carcinoma, skull-base lesions, sinonasal tumours and benign nasopharyngeal masses: if a tumour is found, the patient enters the oncology pathway; if it is excluded, the OME algorithm continues. This nasopharyngeal examination of the adult unilateral effusion is the single most important safety step in the chapter.
- Children — failed hearing screen, speech/language delay, school/behavioural concerns, inattention, balance disturbance, mouth breathing, incidental
- Adults — hearing loss, ear fullness, aural pressure, autophony, tinnitus, unilateral effusion
- Adult unilateral OME = nasopharyngeal carcinoma until proven otherwise (new-onset, persistent, no prior OME)
- Associated neck mass/nasal obstruction/epistaxis/cranial neuropathy/weight loss → nasopharyngoscopy + imaging; tumour → oncology, excluded → continue
★ High-yield pearls (chapter-wide)
- Adult unilateral otitis media with effusion is nasopharyngeal carcinoma until proven otherwise — examine the nasopharynx (nasopharyngoscopy, with imaging) before attributing it to Eustachian-tube dysfunction.
- OME is not treated with antibiotics, steroids, antihistamines or decongestants — none changes the natural history, and the management is watchful waiting or surgery, not medication.
- The high-risk child is not watched for three months — permanent hearing loss, cleft palate, a craniofacial or genetic syndrome, developmental delay or autism warrants immediate audiological and developmental assessment and a lower surgical threshold.
- Functional impairment is as important as the audiogram — speech-language delay, school difficulty and quality-of-life impact drive the decision to operate as much as the measured hearing level.
- Pneumatic otoscopy is the primary diagnostic test, and a type B tympanogram makes OME highly likely while a type C points to Eustachian-tube dysfunction.
- Persistent OME beyond twelve months warrants aggressive surveillance for retraction pockets, atelectasis, ossicular erosion and cholesteatoma — a retraction or cholesteatoma is an indication for early surgery even when the hearing loss is modest.
- Bilateral myringotomy and tympanostomy tubes are the gold-standard intervention for persistent symptomatic OME, giving immediate hearing improvement and better quality of life.
- Adenoidectomy is added at first tube insertion only for nasal obstruction or adenoid disease, but is considered at repeat tube insertion regardless of nasal symptoms, particularly over the age of four.
- Tube otorrhoea is treated with topical fluoroquinolone drops first — systemic antibiotics are reserved for cellulitis, systemic illness or severe infection.
- Routine water precautions are no longer recommended for most children with tympanostomy tubes — restrict only for recurrent otorrhoea, contaminated water or deep diving.
Evidence base
2 sources- HIGH
Rosenfeld RM, Shin JJ, Schwartz SR · Otolaryngol Head Neck Surg · 2016Practice guidelinePMID 26832942
AAO-HNS clinical practice guideline on otitis media with effusion, covering the presentation, diagnosis and management framework.
- MOD
Shah S, Khalil A, Ahmed A · Acta Otolaryngol · 2026Journal articlePMID 41553000
Review of the current management of adults with persistent unilateral otitis media with effusion, where nasopharyngeal carcinoma must be excluded.
Decision tree
An adult unilateral effusion exits to exclude nasopharyngeal carcinoma. The confirmed paediatric effusion is split by risk — the high-risk child is fast-tracked — then staged by duration and hearing, with the decision to operate driven by functional impact and the state of the drum.